Berkeley Lights, Inc. reiterated revenue guidance for full year 2022. For the period, the company reiterates full year 2022 revenue to grow approximately 30% compared to full year 2021.
Bruker Cellular Analysis, Inc.
Equities
BLI
US0843101017
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+34.01% | 51.07B | |
+34.21% | 38.61B | |
-8.02% | 38.78B | |
-8.98% | 27.32B | |
+12.56% | 26.35B | |
-19.62% | 19.46B | |
+39.18% | 13.58B | |
+31.47% | 12.46B | |
-3.40% | 11.75B |